Business Context and Reporting Period
P3 Health Partners Inc. filed a Form 8-K reporting an executive accounting personnel change. The report covers events beginning January 19, 2023, with the filing signed January 25, 2023.
Executive and Accounting Changes
- Erin Darakjian resigned as Chief Accounting Officer effective January 27, 2023.
- The company stated that the resignation was a personal decision and was not related to any disagreement concerning operations, policies, accounting principles, practices, or controls.
- On January 24, 2023, the Board designated Chief Financial Officer Atul Kavthekar as principal accounting officer effective January 27, 2023.
- Biographical information for Mr. Kavthekar was incorporated by reference to the company’s December 1, 2022 Form 8-K.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial performance metrics.
Outlook, Risks, and Unusual Items
No guidance, outlook, material contingencies, or unusual financial items are disclosed. The reported change in accounting leadership may be relevant to investors monitoring financial reporting continuity, although management expressly stated that the departure did not involve disagreements over accounting or controls.
Important Facts to Verify
- Confirm the effective transition date of January 27, 2023.
- Review the December 1, 2022 Form 8-K for Mr. Kavthekar’s background and qualifications.
- Monitor subsequent filings for any additional changes in accounting personnel, financial reporting controls, or disclosure of transition-related issues.
- Note that this Form 8-K contains no updated financial results or guidance.